SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-19-000407
Filing Date
2019-10-24
Accepted
2019-10-24 14:41:35
Documents
59
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q rgbp063019form10q.htm 10-Q 1694436
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 8155
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 8211
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4815
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4815
  Complete submission text file 0001607062-19-000407.txt   5600850

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rgbp-20190630.xml EX-101.INS 991055
7 XBRL SCHEMA FILE rgbp-20190630.xsd EX-101.SCH 63750
8 XBRL CALCULATION FILE rgbp-20190630_cal.xml EX-101.CAL 46803
9 XBRL DEFINITION FILE rgbp-20190630_def.xml EX-101.DEF 209123
10 XBRL LABEL FILE rgbp-20190630_lab.xml EX-101.LAB 297421
11 XBRL PRESENTATION FILE rgbp-20190630_pre.xml EX-101.PRE 268039
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-191725 | Film No.: 191166132
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences